Stefan Harsanyi

CanPharma

CanPharma deals with all aspects of the medical cannabis value chain, from research and development, cultivation and distribution to consulting and training for doctors and pharmacists. The health of the patients and improving quality of life is always the highest priority. Medical cannabis has a broad and varied therapeutic spectrum and can improve the quality of life of critically ill patients in particular. As a pharmaceutical wholesaler / distributor we supply pharmacies all over Germany, thus ensuring that patients have access to cannabis of pharmaceutical quality. All products meet high quality standards including GMP standards. Together with an international network of R&D partners, CanPharma focuses on the research of the cannabis plant and its cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD), terpenes and flavonoids, as well as the development of medical cannabis products. The team is composed of highly qualified physicians, researchers and pharmaceutical experts with many years of experience and specialized in the therapeutic use of cannabis as medicine. The close cooperation with its cultivation partners allows CanPharma to have complete control over the development of product variation, stability and quality.